GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Other Non-Current Assets (2009 - 2026)

Updated

Gsk (GSK) recorded Other Non-Current Assets of $3.56 billion in the quarter ended Jun 30, 2026, up 33.5% from $2.67 billion a year earlier and up 11.8% from the prior quarter.

Analysis

Gsk (GSK) Other Non-Current Assets (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk reported Other Non-Current Assets of $2.83 billion, up 14.1% from the prior year.

  • Annual Other Non-Current Assets has increased for three straight years, with a five-year compound annual growth rate of 16.2% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Other Non-Current Assets came in at $2.48 billion in the year ended Dec 31, 2024 (+26.0%), $1.97 billion in the year ended Dec 31, 2023 (+33.3%), $1.48 billion in the year ended Dec 31, 2022 (-35.9%) and $2.31 billion in the year ended Dec 31, 2021 (+72.5%).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Other Non-Current Assets in data going back to the quarter ended Mar 31, 2009.
  • On a year-over-year basis, Other Non-Current Assets has increased for 12 consecutive quarters, with growth averaging 28.9% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 73.3% in the quarter ended Sep 30, 2024, against a decline of 97.6% in the quarter ended Mar 31, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.18 billion (quarter ended Mar 31, 2026), $2.86 billion (quarter ended Dec 31, 2025) and $2.88 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 14.27 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 10.73 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 4.75 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 9.94 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 3.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.56 Bn
Mar 31, 2026 3.18 Bn
Dec 31, 2025 2.86 Bn
Sep 30, 2025 2.88 Bn
Jun 30, 2025 2.67 Bn
Mar 31, 2025 2.55 Bn
Dec 31, 2024 2.49 Bn
Sep 30, 2024 2.52 Bn
Jun 30, 2024 2.18 Bn
Mar 31, 2024 2.10 Bn
Dec 31, 2023 1.97 Bn
Sep 30, 2023 1.45 Bn
Jun 30, 2023 1.75 Bn
Mar 31, 2023 1.82 Bn
Dec 31, 2022 1.40 Bn
Sep 30, 2022 1.38 Bn
Jun 30, 2022 2.19 Bn
Mar 31, 2022 32.20 Mn
Dec 31, 2021 2.26 Bn
Sep 30, 2021 1.72 Bn
API Access

Gsk Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GSK&period=max&api_key=YOUR_API_KEY